| Literature DB >> 29515024 |
Valérie Besnard1, Rania Dagher1, Tania Madjer1, Audrey Joannes1, Madeleine Jaillet1, Martin Kolb2, Philippe Bonniaud3, Lynne A Murray4,5, Matthew A Sleeman4, Bruno Crestani1,6,7.
Abstract
Periplakin is a component of the desmosomes that acts as a cytolinker between intermediate filament scaffolding and the desmosomal plaque. Periplakin is strongly expressed by epithelial cells in the lung and is a target antigen for autoimmunity in idiopathic pulmonary fibrosis. The aim of this study was to determine the role of periplakin during lung injury and remodeling in a mouse model of lung fibrosis induced by bleomycin. We found that periplakin expression was downregulated in the whole lung and in alveolar epithelial cells following bleomycin-induced injury. Deletion of the Ppl gene in mice improved survival and reduced lung fibrosis development after bleomycin-induced injury. Notably, Ppl deletion promoted an antiinflammatory alveolar environment linked to profound changes in type 2 alveolar epithelial cells, including overexpression of antiinflammatory cytokines, decreased expression of profibrotic mediators, and altered cell signaling with a reduced response to TGF-β1. These results identify periplakin as a previously unidentified regulator of the response to injury in the lung.Entities:
Keywords: Fibrosis; Inflammation; Macrophages; Mouse models; Pulmonology
Mesh:
Substances:
Year: 2018 PMID: 29515024 PMCID: PMC5922284 DOI: 10.1172/jci.insight.90163
Source DB: PubMed Journal: JCI Insight ISSN: 2379-3708